Cargando…

Inflammation Pharmacological Reaction and YMDD Mutational Patterns in Lamivudine Therapeutics Hepatitis B Virus

Background/Aims: Emergence of tyrosine-methionine-aspartate-aspartate (YMDD) motif in reverse transcriptase is a serious problem in chronic hepatitis B(CHB) patients after Lamivudine (LAM) therapy. However, the relationship between inflammation pharmacological reaction and YMDD mutational patterns o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hongcan, Wan, Zemin, She, Lanhui, Zhu, Yajuan, Cai, Zhiliang, Wu, Bin, Zhuang, Qizhen, Ke, Peifeng, Wu, Xinzhong, Li, Zhuo, Huang, Xianzhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081950/ https://www.ncbi.nlm.nih.gov/pubmed/33935748 http://dx.doi.org/10.3389/fphar.2021.648170

Ejemplares similares

YMDD motif mutation after lamivudine therapy
por: Jazayeri, Seyed Mohammad, et al.
Publicado: (2011)

The Clinical Value of Oxymatrine in Preventing Lamivudine Induced YMDD Mutation: A Meta-Analysis
por: He, Min, et al.
Publicado: (2015)

Viral quasispecies of hepatitis B virus in patients with YMDD mutation and lamivudine resistance may not predict the efficacy of lamivudine/adefovir rescue therapy
por: Wang, Changtai, et al.
Publicado: (2019)

Detection of YMDD Motif Mutants by Oligonucleotide Chips in Lamivudine-Untreated Patients with Chronic Hepatitis B Virus Infection
por: Heo, Jeong, et al.
Publicado: (2004)

Probing rate of YMDD motif mutant in lamivudine treatment of Iranian patients with chronic hepatitis B virus infection
por: Ghandehari, Freshte, et al.
Publicado: (2011)

The Naturally Occurring YMDD Mutation among Patients Chronically Infected HBV and Untreated with Lamivudine: A Systematic Review and Meta-Analysis
por: Tan, Youwen, et al.
Publicado: (2012)

A comparative evaluation of the analytical performances of Capillarys 2 Flex Piercing, Tosoh HLC-723 G8, Premier Hb9210, and Roche Cobas c501 Tina-quant Gen 2 analyzers for HbA(1c) determination
por: Wu, Xiaobin, et al.
Publicado: (2016)

Novel mutation in YMDD motif and direct neighbourhood in a child with chronic HBV-infection and clinical lamivudine and adefovir resistance - a scholarly case
por: Schildgen, Verena, et al.
Publicado: (2010)

YMDD Motif Mutation Profile Among Patients Receiving Liver Transplant Due to Hepatitis B Virus Infection With Long Term Lamivudine/Immunoglobulin Therapy
por: Rahimi, Rahim, et al.
Publicado: (2015)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

Compensatory variances of drug-induced hepatitis B virus YMDD mutations
por: Cai, Ying, et al.
Publicado: (2016)

Determination of serum 25-hydroxyvitamin D status among population in southern China by a high accuracy LC-MS/MS method traced to reference measurement procedure
por: Cai, Zhiliang, et al.
Publicado: (2020)

Correction to: Determination of serum 25-hydroxyvitamin D status among population in southern China by a high accuracy LC-MS/MS method traced to reference measurement procedure
por: Cai, Zhiliang, et al.
Publicado: (2021)

Editorial: Insights in Inflammation Pharmacology: 2021
por: Patrignani, Paola, et al.
Publicado: (2022)

Editorial: Women in Inflammation Pharmacology: 2021
por: Patrignani, Paola
Publicado: (2022)

Editorial: Methods and applications in inflammation pharmacology
por: Schmidtchen, Artur, et al.
Publicado: (2022)

Editorial: Insights in inflammation pharmacology: 2022
por: Patrignani, Paola, et al.
Publicado: (2023)

Editorial: Global excellence in inflammation pharmacology
por: Saha, Sukanya, et al.
Publicado: (2023)

Editorial: Pharmacological Approaches Targeting Neutrophilic Inflammation
por: Chernyak, Boris V., et al.
Publicado: (2021)

SMG9 Serves as an Oncogene to Promote the Tumor Progression via EMT and Wnt/β-Catenin Signaling Pathway in Hepatocellular Carcinoma
por: Jin, Xing, et al.
Publicado: (2021)

Natural YMDD motif mutations in treatment naïve patients with chronic hepatitis B in Huzhou of eastern China
por: Qian, Fuchu, et al.
Publicado: (2016)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases
por: Wang, Xiaoping, et al.
Publicado: (2022)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Detection of mixed populations of wild-type and YMDD hepatitis B variants by pyrosequencing in acutely and chronically infected patients
por: Mello, Francisco C A, et al.
Publicado: (2012)

The Interventional Effects of Tubson-2 Decoction on Ovariectomized Rats as Determined by a Combination of Network Pharmacology and Metabolomics
por: Yang, Fan, et al.
Publicado: (2020)

Pharmacological OGG1 inhibition decreases murine allergic airway inflammation
por: Tanner, Lloyd, et al.
Publicado: (2022)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases, volume II
por: Yan, Aiwei, et al.
Publicado: (2023)

Role of Human Organic Cation Transporter 1 (hOCT1) Polymorphisms in Lamivudine (3TC) Uptake and Drug-Drug Interactions
por: Arimany-Nardi, Cristina, et al.
Publicado: (2016)

The pharmacology, pharmacokinetics, and toxicity of spinosin: A mini review
por: Kuang, Xiaolan, et al.
Publicado: (2022)

Screening for Anti-Inflammation Quality Markers of Lianhua Qingwen Capsule Based on Network Pharmacology, UPLC, and Biological Activity
por: Zhou, Yongfeng, et al.
Publicado: (2021)

Advances in Chemical Constituents, Clinical Applications, Pharmacology, Pharmacokinetics and Toxicology of Erigeron breviscapus
por: Wu, Ruixia, et al.
Publicado: (2021)

Pharmacological Inhibition of Serine Proteases to Reduce Cardiac Inflammation and Fibrosis in Atrial Fibrillation
por: Coppini, Raffaele, et al.
Publicado: (2019)

Simultaneous quantitation of 17 endogenous adrenal corticosteroid hormones in human plasma by UHPLC-MS/MS and their application in congenital adrenal hyperplasia screening
por: Zhang, Qiaoxuan, et al.
Publicado: (2022)

Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological Investigation
por: Wang, Zihao, et al.
Publicado: (2019)

Systems Pharmacology-Based Strategy to Investigate Pharmacological Mechanisms of Radix Puerariae for Treatment of Hypertension
por: Wu, Wenting, et al.
Publicado: (2020)

Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation
por: Lei, Sisi, et al.
Publicado: (2022)

Detection of rtN236T mutation associated with adefovir dipivoxil resistance in Hepatitis B infected patients with YMDD mutations in Tehran
por: Monavari, Seyed Hamidreza, et al.
Publicado: (2013)

Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the Sanguisorba Officinalis in Suppressing Hepatocellular Carcinoma
por: Jiang, Nan, et al.
Publicado: (2021)

Unraveling the Pharmacological Potential of Lichen Extracts in the Context of Cancer and Inflammation With a Broad Screening Approach
por: Ingelfinger, Rebecca, et al.
Publicado: (2020)

Advances in the therapeutic application and pharmacological properties of kinsenoside against inflammation and oxidative stress-induced disorders
por: Lu, Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_20v852q7mh3kr0ig0r41p9qqqn